Int Arch Allergy Immunol. 2018;176(2):106-114. doi: 10.1159/000487556. Epub 2018 Apr 3.
Acetaminophen is the most commonly used antipyretic in children. However, there are limited data assessing hypersensitivity reactions related to acetaminophen usage.
To conduct a systematic review to characterize reported reactions to acetaminophen in adults and children, and perform a meta-analysis to assess the prevalence of acetaminophen hypersensitivity in children with a suspected acetaminophen allergy.
We performed a systematic review of studies reporting hypersensitivity reactions to acetaminophen by searching 2 electronic databases. From the selected studies, we included those assessing the prevalence of acetaminophen hypersensitivity by performing oral challenge in our meta-analysis.
Eighty-five studies were included in the systematic review, assessing a total of 1,030 participants. Immediate (within 1 h of exposure) hypersensitivity reactions were reported in > 25% of the articles, while cutaneous nonimmediate reactions were similarly reported in about 25% of the articles. The remaining articles reported Steven-Johnson syndrome/toxic epidermal necrolysis, fixed drug eruptions, and cross-intolerance reactions. Five pediatric studies were included in our meta-analysis. The prevalence of acetaminophen hypersensitivity reaction among children undergoing oral challenge was 10.1% (95% confidence interval 4.5-15.5).
Future studies assessing the risk of immediate and nonimmediate hypersensitivity reactions to acetaminophen and elucidating the mechanism of acetaminophen hypersensitivity reactions are required.
对乙酰氨基酚是儿童最常用的解热药。然而,评估与对乙酰氨基酚使用相关的过敏反应的相关数据有限。
进行系统评价,以描述成人和儿童中报告的对乙酰氨基酚的反应,并进行荟萃分析,以评估疑似对乙酰氨基酚过敏的儿童中对乙酰氨基酚过敏的发生率。
我们通过搜索 2 个电子数据库,对报告对乙酰氨基酚过敏反应的研究进行了系统评价。从选定的研究中,我们纳入了通过口服挑战评估对乙酰氨基酚过敏发生率的研究进行荟萃分析。
系统评价共纳入 85 项研究,评估了共 1030 名参与者。>25%的文章报告了即刻(暴露后 1 小时内)过敏反应,而约 25%的文章同样报告了皮肤非即刻反应。其余文章报告了史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症、固定药物疹和交叉不耐受反应。我们的荟萃分析纳入了 5 项儿科研究。接受口服挑战的儿童中对乙酰氨基酚过敏反应的发生率为 10.1%(95%置信区间 4.5-15.5)。
需要进一步研究评估对乙酰氨基酚即刻和非即刻过敏反应的风险,并阐明对乙酰氨基酚过敏反应的机制。